Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 2
2010 1
2011 1
2013 1
2014 1
2016 2
2017 1
2018 2
2019 1
2020 3
2021 7
2022 12
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia.
Rausch C, Rothenberg-Thurley M, Dufour A, Schneider S, Gittinger H, Sauerland C, Görlich D, Krug U, Berdel WE, Woermann BJ, Hiddemann W, Braess J, von Bergwelt-Baildon M, Spiekermann K, Herold T, Metzeler KH. Rausch C, et al. Leukemia. 2023 Jun;37(6):1234-1244. doi: 10.1038/s41375-023-01884-2. Epub 2023 Apr 11. Leukemia. 2023. PMID: 37041198 Free PMC article.
Friday Leukemia-a Structural Phenomenon.
Rausch C, Arnreich C, Rothenberg-Thurley M, Dufour A, Schneider S, Gittinger H, Bücklein V, Subklewe M, Sauerland C, Görlich D, Krug U, Berdel WE, Wörmann BJ, Hiddemann W, Braess J, von Bergwelt-Baildon M, Spiekermann K, Metzeler KH, Herold T. Rausch C, et al. Dtsch Arztebl Int. 2024 Feb 9;121(3):94-95. doi: 10.3238/arztebl.m2023.0260. Dtsch Arztebl Int. 2024. PMID: 38471183 Free PMC article. No abstract available.
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.
Wirth AK, Wange L, Vosberg S, Henrich KO, Rausch C, Özdemir E, Zeller CM, Richter D, Feuchtinger T, Kaller M, Hermeking H, Greif PA, Senft D, Jurinovic V, Bahrami E, Jayavelu AK, Westermann F, Mann M, Enard W, Herold T, Jeremias I. Wirth AK, et al. Among authors: rausch c. Leukemia. 2022 Dec;36(12):2863-2874. doi: 10.1038/s41375-022-01726-7. Epub 2022 Nov 4. Leukemia. 2022. PMID: 36333584 Free PMC article.
[Acute Myeloid Leukemia - Update 2022].
Rausch C, Hiddemann W, von Bergwelt-Baildon M, Spiekermann K, Herold T. Rausch C, et al. Dtsch Med Wochenschr. 2022 Sep;147(17):1108-1114. doi: 10.1055/a-1758-2452. Epub 2022 Aug 28. Dtsch Med Wochenschr. 2022. PMID: 36030783 German.
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.
Eckardt JN, Bill M, Rausch C, Metzeler K, Spiekermann K, Stasik S, Sauer T, Scholl S, Hochhaus A, Crysandt M, Brümmendorf TH, Krug U, Wörmann B, Hiddemann W, Görlich D, Sauerland C, Steffen B, Einsele H, Neubauer A, Burchert A, Schäfer-Eckart K, Berdel WE, Schliemann C, Krause SW, Hänel M, Hanoun M, Kaufmann M, Fransecky L, Braess J, Ruhnke L, Schetelig J, Middeke JM, Serve H, Baldus CD, Platzbecker U, Müller-Tidow C, Bornhäuser M, Herold T, Thiede C, Röllig C. Eckardt JN, et al. Among authors: rausch c. Leukemia. 2023 Nov;37(11):2282-2285. doi: 10.1038/s41375-023-02016-6. Epub 2023 Sep 7. Leukemia. 2023. PMID: 37679502 Free PMC article. No abstract available.
Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance.
Sardella M, Belcher G, Lungu C, Ignoni T, Camisa M, Stenver DI, Porcelli P, D'Antuono M, Castiglione NG, Adams A, Furlan G, Grisoni I, Hall S, Boga L, Mancini V, Ciuca M, Chonzi D, Edwards B, Mangoni AA, Tuccori M, Prokofyeva E, De Gregorio F, Bertazzoli Grabinski Broglio M, van Leeuwen B, Kruger P, Rausch C, Le Louet H. Sardella M, et al. Among authors: rausch c. Ther Adv Drug Saf. 2021 Aug 5;12:20420986211038436. doi: 10.1177/20420986211038436. eCollection 2021. Ther Adv Drug Saf. 2021. PMID: 34394910 Free PMC article. Review.
Genomic landscape of metastatic colorectal cancer.
Haan JC, Labots M, Rausch C, Koopman M, Tol J, Mekenkamp LJ, van de Wiel MA, Israeli D, van Essen HF, van Grieken NC, Voorham QJ, Bosch LJ, Qu X, Kabbarah O, Verheul HM, Nagtegaal ID, Punt CJ, Ylstra B, Meijer GA. Haan JC, et al. Among authors: rausch c. Nat Commun. 2014 Nov 14;5:5457. doi: 10.1038/ncomms6457. Nat Commun. 2014. PMID: 25394515 Free PMC article. Clinical Trial.
Consensus molecular subtype classification of colorectal adenomas.
Komor MA, Bosch LJ, Bounova G, Bolijn AS, Delis-van Diemen PM, Rausch C, Hoogstrate Y, Stubbs AP, de Jong M, Jenster G, van Grieken NC, Carvalho B, Wessels LF, Jimenez CR, Fijneman RJ, Meijer GA; NGS-ProToCol Consortium:. Komor MA, et al. Among authors: rausch c. J Pathol. 2018 Nov;246(3):266-276. doi: 10.1002/path.5129. Epub 2018 Aug 31. J Pathol. 2018. PMID: 29968252 Free PMC article.
Guselkumab demonstrates long-term efficacy and maintenance of treatment response post-withdrawal in systemic-treatment naïve patients and non-responders to fumaric acid esters: Results from parts II and III of a randomised, active-comparator-controlled phase IIIb trial (POLARIS).
Thaҫi D, Pinter A, Sebastian M, Termeer C, Sticherling M, Gerdes S, Schäkel K, Wegner S, Krampe S, Bartz H, Rausch C, Taut F, Eyerich K. Thaҫi D, et al. Among authors: rausch c. Br J Dermatol. 2023 Dec 22:ljad523. doi: 10.1093/bjd/ljad523. Online ahead of print. Br J Dermatol. 2023. PMID: 38133615
Modeling early treatment response in AML from cell-free tumor DNA.
Wang D, Rausch C, Buerger SA, Tschuri S, Rothenberg-Thurley M, Schulz M, Hasenauer J, Ziemann F, Metzeler KH, Marr C. Wang D, et al. Among authors: rausch c. iScience. 2023 Oct 19;26(12):108271. doi: 10.1016/j.isci.2023.108271. eCollection 2023 Dec 15. iScience. 2023. PMID: 38047080 Free PMC article.
39 results